The hospital will use qER to automate the detection of abnormalities on noncontrast CT scans, including intracranial hemorrhages caused by trauma, accidents, or strokes, according to a press statement.

qER has been cleared by the U.S. Food and Drug Administration (FDA) and has EU Medical Device Regulation Class IIb status.